drugset / Trial / NCT03912220

Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration

NCT03912220

RandomizedParallel-groupDouble-blindPrevention

Summary

This study will evaluate the effects of a nutritional supplement called nicotinamide riboside in preventing small fiber nerve degeneration that is experimentally induced by applying capsaicin to skin in otherwise healthy study participants. Furthermore, the effects on nerve regeneration will also be evaluated. The results will be compared to a placebo control drug.

Timeline

Start
2020-09-01
Primary completion
2023-05-01
Completion
2023-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotinamide riboside Small molecule 900 mg Oral